These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 34142831

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.
    Merritt JM, Viswanath SK, Stephenson GA.
    Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819
    [Abstract] [Full Text] [Related]

  • 23. Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulations.
    Lai A, Sahbaz Y, Ford L, Nguyen TH, Haque S, Williams HD, Benameur H, Scammells PJ, Porter CJH.
    Int J Pharm; 2021 Mar 15; 597():120292. PubMed ID: 33581479
    [Abstract] [Full Text] [Related]

  • 24. Salt formation to improve drug solubility.
    Serajuddin AT.
    Adv Drug Deliv Rev; 2007 Jul 30; 59(7):603-16. PubMed ID: 17619064
    [Abstract] [Full Text] [Related]

  • 25. Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug-buffer aggregates.
    Marković OS, Pešić MP, Shah AV, Serajuddin ATM, Verbić TŽ, Avdeef A.
    Eur J Pharm Sci; 2019 May 15; 133():264-274. PubMed ID: 30914359
    [Abstract] [Full Text] [Related]

  • 26. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.
    Mohan S, Li Y, Chu K, De La Paz L, Sperger D, Shi B, Foti C, Rucker V, Lai C.
    Mol Pharm; 2024 May 06; 21(5):2590-2605. PubMed ID: 38656981
    [Abstract] [Full Text] [Related]

  • 27. Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.
    Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA.
    J Pharm Sci; 1986 May 06; 75(5):492-6. PubMed ID: 3735089
    [Abstract] [Full Text] [Related]

  • 28. The Effect of In-Situ-Generated Moisture on Disproportionation of Pharmaceutical Salt.
    Weldeab AO, McElderry JD, Lin Y.
    Mol Pharm; 2023 Jan 02; 20(1):561-571. PubMed ID: 36524757
    [Abstract] [Full Text] [Related]

  • 29. Impact of sertraline salt form on the oxidative stability in powder blends.
    Hsieh YL, Yu W, Xiang Y, Pan W, Waterman KC, Shalaev EY, Shamblin SL, Taylor LS.
    Int J Pharm; 2014 Jan 30; 461(1-2):322-30. PubMed ID: 24325937
    [Abstract] [Full Text] [Related]

  • 30. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810.
    Hou HH, Jia W, Liu L, Cheeti S, Li J, Nauka E, Nagapudi K.
    Pharm Res; 2018 Jan 29; 35(2):37. PubMed ID: 29380076
    [Abstract] [Full Text] [Related]

  • 31. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.
    Lee HL, Vasoya JM, Cirqueira ML, Yeh KL, Lee T, Serajuddin AT.
    Mol Pharm; 2017 Apr 03; 14(4):1278-1291. PubMed ID: 28245127
    [Abstract] [Full Text] [Related]

  • 32. Machine-Vision-Enabled Salt Dissolution Analysis.
    Štukelj J, Agopov M, Yliruusi J, Strachan CJ, Svanbäck S.
    Anal Chem; 2020 Jul 21; 92(14):9730-9738. PubMed ID: 32544319
    [Abstract] [Full Text] [Related]

  • 33. Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.
    Vasoya JM, Shah AV, Serajuddin ATM.
    ADMET DMPK; 2019 Jul 21; 7(2):106-130. PubMed ID: 35350544
    [Abstract] [Full Text] [Related]

  • 34. Preformulation studies of dovitinib free base: Solubility, lipophilicity and stability.
    Sripetch S, Ryzhakov A, Loftsson T.
    Int J Pharm; 2022 May 10; 619():121721. PubMed ID: 35398252
    [Abstract] [Full Text] [Related]

  • 35. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA, Ji Q, Joshi YM, Serajuddin AT.
    Int J Pharm; 2007 Jun 07; 337(1-2):210-8. PubMed ID: 17296277
    [Abstract] [Full Text] [Related]

  • 36. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
    Williams HD, Ford L, Han S, Tangso KJ, Lim S, Shackleford DM, Vodak DT, Benameur H, Pouton CW, Scammells PJ, Porter CJH.
    Mol Pharm; 2018 Dec 03; 15(12):5678-5696. PubMed ID: 30376336
    [Abstract] [Full Text] [Related]

  • 37. Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.
    Hsieh YL, Taylor LS.
    Pharm Res; 2015 Feb 03; 32(2):549-61. PubMed ID: 25145335
    [Abstract] [Full Text] [Related]

  • 38. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis.
    Modi D, Jonnalagadda S, Campbell GA, Dalwadi G.
    J Pharm Sci; 2023 Sep 03; 112(9):2427-2443. PubMed ID: 36958691
    [Abstract] [Full Text] [Related]

  • 39. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N, Suryanarayanan R.
    Mol Pharm; 2021 Jul 05; 18(7):2683-2693. PubMed ID: 34061524
    [Abstract] [Full Text] [Related]

  • 40. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A.
    Eur J Pharm Sci; 2017 Dec 15; 110():2-18. PubMed ID: 28392495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.